GLP-1 Drug Prescribed to Woman with Eating Disorder via Telehealth

Hepatitis E is a viral liver infection caused by the hepatitis E virus (HEV). This virus is primarily transmitted through contaminated water and food, making it a significant public health concern in areas with poor sanitation. While hepatitis E is often self-limiting and resolves on its own, it can cause severe complications in certain populations, particularly pregnant women and individuals with weakened immune systems. Laboratory testing plays a crucial role in diagnosing hepatitis E and distinguishing it from other types of viral hepatitis.

The primary laboratory tests used to diagnose hepatitis E include serological tests that detect antibodies against the virus and molecular tests that identify the viral genetic material. Anti-HEV IgM antibodies appear early in the infection and indicate acute or recent infection, while anti-HEV IgG antibodies develop later and can persist for years, suggesting past exposure or immunity. Blood tests may also reveal elevated liver enzymes, particularly alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which indicate liver inflammation and damage. Additionally, bilirubin levels may be elevated, leading to jaundice, a common symptom of hepatitis E.

Molecular testing methods such as reverse transcription polymerase chain reaction (RT-PCR) can detect HEV RNA in blood or stool samples. This test is particularly useful for confirming active infection and monitoring viral load, especially in immunocompromised patients who may not produce adequate antibody responses. RT-PCR testing can also help identify the specific genotype of the virus, which has implications for understanding transmission patterns and potential treatment approaches. In some cases, liver function tests are performed repeatedly to monitor the progression of the disease and assess recovery.

For individuals suspected of having hepatitis E, healthcare providers typically begin with serological testing for anti-HEV IgM and IgG antibodies combined with liver function tests. If results are inconclusive or if the patient has a compromised immune system, molecular testing may be recommended. Early and accurate diagnosis is essential for appropriate patient management, particularly in high-risk groups such as pregnant women, where hepatitis E can lead to severe outcomes including acute liver failure. Understanding these laboratory tests helps patients and healthcare providers make informed decisions about diagnosis, treatment, and prevention strategies.